Applications of (1S,2S)-N,N'-Dimethyl-1,2-Cyclohexanediamine in Industrial Manufacturing

As a specialized producer of (1S,2S)-N,N'-Dimethyl-1,2-Cyclohexanediamine, we support leading manufacturers in demanding sectors with batch-to-batch consistency and detailed technical guidance. Below, we detail recognized industrial applications where our material is directly integrated, highlighting practical formulation parameters, compliance requirements, process integration points, and established end products in each sector.

1. Catalysts for Asymmetric Hydrogenation in Pharmaceutical Synthesis

This diamine is a well-validated chiral ligand in homogeneous catalytic hydrogenation—especially for synthesizing active pharmaceutical intermediates. Its defined stereochemistry drives high enantioselectivity, instrumental for API manufacturing under stringent impurity controls. Our technical support ensures rapid scale-up for commercial reactors post-lab screening, with precise documentation for regulatory submission requirements.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice
• EU GMP for Active Substances
• USP and EP reference standards for APIs
• FDA 21 CFR Part 211 (where relevant to final API integration)

Typical usage ratio

• 0.5 – 2 mol% relative to metal catalyst, adjusted according to substrate complexity and required optical purity

Downstream process integration

• Added in the ligand coordination step during pre-catalyst formation ahead of substrate feed
• Deployed in pressure hydrogenation reactors at kilo-lab and commercial scale
• Recovered or neutralized post-reaction under validated cleaning protocols

Final product types

• Chiral pharmaceutical intermediates (e.g., amino alcohols, β-lactams)
• Enantiopure APIs for CNS, anti-infective, and cardiovascular drug products

2. Chiral Auxiliaries in Agrochemical Active Ingredient Manufacturing

Our diamine serves leading crop protection suppliers as a building block for creating enantio-enriched intermediates, particularly in routes demanding precise control over stereospecificity. Used during key bond-forming steps, this allows clients to meet regulatory standards on isomer content in agrochemical actives. Traceability and batch certification accompany each supply for full dossier support.

Industry compliance standards

• FAO/WHO pesticide specification guidelines
• ISO 17025 laboratory accreditation for QA testing
• REACH registration for environmental data submission in EU markets
• OECD Good Laboratory Practice (GLP) for synthesis validation

Typical usage ratio

• 1 – 3 mol% per chiral catalytic cycle; process chemistry teams refine loading during scale-up studies

Downstream process integration

• Introduced in the stereocontrolled cyclization or reductive amination stage of A.I. synthesis
• Byproduct residues removed via aqueous or chromatographic wash after conversion

Final product types

• Enantio-enriched crop protection actives (e.g., selective herbicide and fungicide intermediates)
• Chiral boosters for new-generation insecticides

3. Polyurethane and Epoxy Resin Curing Agent Synthesis

Chemical and plastics manufacturers incorporate this diamine as an intermediate in advanced amine curing agents for high-performance epoxy and polyurethane systems. The molecular structure delivers cycloaliphatic rigidity that enhances mechanical properties in composite coatings and structural adhesives, compliant with the chemical resistance and emission profiles required by automotive and electronics sectors.

Industry compliance standards

• ISO 9001 Quality Management
• IEC 61249-2-21 (halogen-free requirements for electronics)
• RoHS Directive (EU Restriction of Hazardous Substances)
• ASTM D638 (tensile strength of plastics)

Typical usage ratio

• 10 – 35 phr (parts per hundred resin) in curing agent blends; optimized for crosslink density and final set time

Downstream process integration

• Reacted by amination or amidation to create advanced hardener formulations
• Blended with polyols or epoxy prepolymers before in-situ curing under controlled temperatures

Final product types

• Thermoset adhesives for automotive assembly
• High-durability composite coatings
• Circuit board encapsulant systems

4. Synthesis of Optically Active Ligands for Fine Chemical Manufacturing

Producers of specialty chemicals and fine chemicals utilize this diamine to create optically active ligand frameworks, key to the selective synthesis of aroma compounds, flavors, and advanced material additives. The tightly controlled chirality enables repeatable downstream transformations with minimized undesired isomers, which aligns with IFRA and food grade ingredient demands.

Industry compliance standards

• IFRA Code of Practice (for aroma chemicals)
• Food Chemicals Codex (FCC) when used for food-grade additives
• ISO 9001:2015
• GFSI-benchmarked food safety standards (for some downstream customers)

Typical usage ratio

• 0.3 – 1.2 molar equivalents relative to metal center in ligand synthesis reactions; precise ratio based on structure and downstream reactivity

Downstream process integration

• Condensation with functionalized haloarenes or aldehydes to produce chiral ligands
• Ligand-metal complexation performed under anhydrous conditions for moisture-sensitive reactions

Final product types

• Stereopure aroma intermediates (e.g., menthol derivatives, aroma isomers)
• Functionalized chiral additives for plastics and ink applications

5. Building Block for Functionalized Polymeric Material Modification

Material science innovators use this cyclohexanediamine derivative as a monomer modifier, introducing well-defined amine functionality into polymer backbones and specialty coatings. The spatial arrangement allows precise tuning of hydrophilicity and chemical resistance for demanding medical device and specialty membrane applications, and batch traceability data is provided for regulatory filing support.

Industry compliance standards

• ISO 10993-5 (cytotoxicity testing for medical materials)
• US FDA 21 CFR 177.1680 (polymers for food contact)
• ISO 14001 Environmental Management
• USP Class VI for certain medical device polymers

Typical usage ratio

• 1 – 8 wt% as a copolymerization or end-capping agent; formulators vary input for target molecular weight and functional group content

Downstream process integration

• Incorporated during bulk or solution polymerization as reactive diluent/introduction agent
• Post-reacted to attach further specialty groups for surface modification

Final product types

• Functionalized polyamides and polyurethanes for medical tubing
• Selective-ion transport membranes in water treatment
• Custom surface-active coatings for precision devices